Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and Evaluation of Functional Visual Field and Navigation Endpoints in Moderate to Profound Inherited Retinal Disease (DEFINE-IRD)

NCT07502664 is registered in ClinicalTrials.gov with Ray Therapeutics, Inc. as lead sponsor.

NCT NCT07502664
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07502664 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and Evaluation of Functional Visual Field and Navigation Endpoints in Moderate to Profound Inherited Retinal Disease (DEFINE-IRD)
Lead sponsor
Ray Therapeutics, Inc.
Phase
Observational
Overall status
Recruiting
Start date
February 19, 2026
Completion date
February 28, 2027
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

geographic atrophy from age-related macular degeneration, retinal dystrophies, retinitis pigmentosa, stargardt disease, stargardt macular dystrophy, x-linked retinoschisis